SOCIETY ENDORSEMENTS
COURSE DIRECTORS
Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern Medical Center
Dallas, Texas
FACULTY
Kimberly Brown, MD
Henry Ford Hospital
Detroit, Michigan
William Chey, MD
University of Michigan
Ann Arbor, Michigan
Ronnie Fass, MD
MetroHealth Medical Center
Detroit, Michigan
Steven Flamm, MD
Rush University Medical Center
Chicago, Illinois
Stephen Hanauer, MD
Northwestern University
Chicago, Illinois
Amneet Hans, MD
Baylor University Medical Center
Dallas, Texas
Jay Horton, MD
University of Texas
Southwestern Medical Center
Dallas, Texas
Prashant Kedia, MD
Methodist Dallas Medical Center
Dallas, Texas
Paul Kwo, MD
Stanford Medicine
Palo Alto, California
Dana Lukin, MD, PhD
Weill Cornell Medicine
New York, New York
Jan Petrasek, MD, PhD
UT Health San Antonio
San Antonio, Texas
Nancy Reau, MD
Rush University Medical Center
Chicago, Illinois
Michael Vaezi, MD, PhD
Vanderbilt University Medical Center
Nashville, Tennessee
John Vierling, MD
Baylor College of Medicine
Houston, Texas
AGENDA
Friday, May 10, 2024
11:45 AM
Lunch and Registration
12:00 PM - 12:45 PM
Learn About Omvoh™️: Some Discoveries Are Too Urgent To Ignore
Shadi Hamdeh, MD and Sharon Rimon, NP
Industry-Sponsored Event (Non-accredited)
Sponsored by Eli Lilly & Company
12:50 PM - 1:05 PM
Welcome
Session I
1:05 PM - 1:30 PM
Primary Biliary Cholangitis (PBC):Health Related Quality of Life and Emerging Therapies
John Vierling, MD
1:30 PM - 1:55 PM
Managing the Patient with Alcohol-associated Hepatitis
Jan Petrasek, MD, PhD
1:55 PM - 2:20 PM
Advanced Cirrhosis: Recognizing and Managing Complications of Portal Hypertension
Paul Kwo, MD
2:20 PM - 2:35 PM
Q&A / Panel Discussion
2:35 PM – 2:50 PM
Break
Session II
2:50 PM - 3:15 PM
Positioning New Therapies For Inflammatory Bowel Disease (IBD)
Stephen Hanauer, MD
3:15 PM - 3:40 PM
Managing Inflammatory Bowel Disease (IBD) During Pregnancy
Amneet Hans, MD
3:40 PM - 4:05 PM
Managing Perianal Crohn’s Disease
Dana Lukin, MD, PhD
4:05 PM - 4:30 PM
Q&A / Panel Discussion
4:30 PM – 5:30 PM
Major Advancement in MASH Management
Parvez Mantry, MD
Independent Symposium (Accredited)
Provided by the Chronic Liver Disease Foundation and the Global NASH Council
5:30 PM - 7:00 PM
Reception
Saturday, May 11, 2024
7:15 AM
Breakfast and Registration
7:30 AM - 8:15 AM
Stelara Real World Evidence in CD & UC
Harry Thomas, MD
Industry-Sponsored Event (Non-accredited)
Sponsored by Johnson & Johnson
8:20 AM – 8:25 AM
Welcome Back
Session III
8:25 AM – 8:55 AM
Managing Refractory GERD
Ronnie Fass, MD
8:55 AM - 9:25 AM
Eosinophilic Esophagitis in 2024:
Standard and Emerging Treatments
Michael Vaezi, MD, PhD
9:25 AM - 9:55 AM
Management of Pancreatic Cysts
Prashant Kedia, MD
9:55 AM - 10:20 AM
Q&A / Panel Discussion
10:20 AM – 10:35 AM
Break
10:35 AM - 11:35 AM
Parallel Session (Select One)
-
Upper GI Woes from Head to Toe
-
Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Pancreas
-
Obesity and Steatosis
-
Chronic Liver Disease
11:35 AM - 11:50 AM
Lunch Break
11:50 AM - 12:35 PM
Now Approved: Rezdiffra™️ (resmetirom)
A New Treatment Option
Kimberly Brown, MD
Industry-Sponsored Event (Non-accredited)
Sponsored By Madrigal Pharmaceuticals
Session IV
12:35 PM - 1:00 PM
Metabolic-Associated Steatotic Liver Disease: Positioning New and Emerging Therapies
Nancy Reau, MD
1:00 PM - 1:45 PM
Pro/Con Debate: Steatotic Liver Disease: Using Non-invasive Tests (NITs) to Measure Disease Progression
Steven Flamm, MD, and Kimberly Brown, MD
1:45 PM - 2:15 PM
Managing Obesity in the Community
Jay Horton, MD
2:15 PM - 2:40 PM
Q&A / Panel Discussion
2:40 PM - 2:55 PM
Break
Session V
2:55 PM - 3:25 PM
Best Practices for Chronic Constipation
William Chey, MD
3:25 PM - 3:55 PM
Getting the BS out of IBS-D: Let’s Make a Diagnosis
Lawrence Schiller, MD
3:55 PM - 4:15 PM
Q&A / Panel Discussion
4:15 PM - 4:30 PM
Meeting Wrap-up
VENUE
The Westin
Dallas Southlake
1200 E. State HWY 114
Southlake, TX 76092
This activity is supported by educational grants from Intercept Pharmaceuticals, Inc., Ipsen Biopharmaceuticals, Inc., and Salix Pharmaceuticals.
This activity is jointly provided by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas, and the Texas Liver Institute.
